Managing a Rare Water Balance Disorder

When someone has diabetes insipidus, their body cannot properly hold on to water, which causes them to produce large amounts of diluted urine throughout the day and night. Most people make between one and three quarts of urine daily, but those with diabetes insipidus can produce up to twenty quarts a day. This constant fluid loss triggers intense thirst and creates a cycle of drinking and urinating that can control every aspect of life.^[1][2]

The goal of treatment is to reduce the amount of urine the body produces, relieve that unrelenting thirst, and prevent dangerous dehydration. Treatment plans are personalized based on the type of diabetes insipidus someone has and how their body responds to therapy. Some people with mild cases may only need to adjust their fluid intake, while others require medication to replace missing hormones or help their kidneys work more effectively.^[10]

The condition is not related to the more common diabetes mellitus (the type that involves high blood sugar and insulin). Despite sharing the word “diabetes,” which refers to excessive urination, these are completely different diseases. In diabetes insipidus, blood sugar levels remain normal. The problem lies with a hormone called arginine vasopressin (also known as antidiuretic hormone or ADH), which tells the kidneys how much water to keep in the body and how much to release as urine.^[3][4]

Standard Medical Approaches to Treatment

The foundation of treating diabetes insipidus depends on what’s causing the condition. There are two main types: one where the body doesn’t make enough of the hormone that controls water balance, and another where the kidneys don’t respond properly to that hormone even when it’s present in normal amounts.^[5]

For people with central diabetes insipidus (formerly called cranial diabetes insipidus), the hypothalamus or pituitary gland in the brain doesn’t produce or release enough arginine vasopressin. This can happen after head injuries, brain surgery, tumors, infections like meningitis, or sometimes for unknown reasons. In these cases, the main treatment involves replacing the missing hormone with a medication called desmopressin.^[6][8]

Desmopressin is a manufactured version of arginine vasopressin that works just like the natural hormone but lasts longer in the body and is more resistant to breaking down. It signals the kidneys to conserve water and produce less urine. The medication comes in several forms: a nasal spray that you inhale through your nose, tablets you swallow, or a form that melts between your gum and lip. Some people also receive it as an injection. Most patients need to take desmopressin two to three times per day, though the exact timing depends on the form used and individual response.^[10][11]

The nasal spray form of desmopressin is absorbed quickly through the nasal passages into the bloodstream. If someone develops a cold or stuffy nose that prevents proper absorption, doctors may temporarily switch them to tablets. The tablet form takes longer to work because it must be absorbed through the digestive system, so patients often need to take them more frequently throughout the day to maintain steady levels.^[11]

Desmopressin is generally very safe to use. The most common side effects are mild and include headaches, stomach pain, feeling sick, blocked or runny nose, and occasional nosebleeds when using the nasal spray. These side effects usually don’t require stopping the medication. Doctors monitor patients closely when they first start treatment to find the right dose that controls symptoms without causing problems.^[11]

For nephrogenic diabetes insipidus, the kidneys don’t respond properly to arginine vasopressin even though the body makes enough of it. This type can be caused by certain medications (especially lithium, used to treat bipolar disorder), kidney damage, genetic disorders, or imbalances in blood calcium or potassium levels. Because the problem is with the kidneys’ response rather than hormone production, desmopressin usually doesn’t work for this type.^[8][11]

If lithium or another medication is causing nephrogenic diabetes insipidus, doctors may consider stopping that drug or switching to an alternative if it’s medically safe to do so. However, many people need to stay on these medications for their primary condition, so other treatment strategies are necessary.^[8]

Treatment for nephrogenic diabetes insipidus often involves a combination of thiazide diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. This might sound counterintuitive because diuretics are commonly known as “water pills” that increase urine production. However, thiazide diuretics work differently in this condition. They slow down the rate at which kidneys filter blood, which paradoxically reduces the amount of diluted urine produced over time.^[11][13]

When NSAIDs are added to thiazide diuretics, they further reduce urine volume. The combination is more effective than either drug alone. However, long-term use of NSAIDs carries risks, particularly the potential for developing stomach ulcers. To protect against this, doctors may prescribe an additional medication called a proton pump inhibitor that reduces stomach acid production.^[11]

Side effects of thiazide diuretics are generally uncommon but can include dizziness when standing up, indigestion, skin that becomes very sensitive to sunlight, and temporary erectile dysfunction in men. These effects usually resolve if the medication is stopped.^[11]

Dietary adjustments can also help manage nephrogenic diabetes insipidus. Reducing salt and protein intake helps the kidneys produce less urine. This might involve eating fewer processed foods, limiting meat, eggs, and nuts, and avoiding adding extra salt to meals. However, dietary changes should only be made under medical supervision to ensure proper nutrition. Doctors and dietitians can provide specific guidance about which foods to reduce while maintaining a balanced diet.^[11]

A rare pregnancy-related form called gestational diabetes insipidus occurs when the placenta produces too much of an enzyme that breaks down arginine vasopressin. This type is more common in women pregnant with multiples or those with liver-affecting conditions like preeclampsia. It’s typically treated with desmopressin and usually resolves within two to three weeks after delivery.^[3]

Regardless of the type of diabetes insipidus, maintaining adequate hydration is essential. People with this condition must have constant access to water and should never have their fluid intake restricted unless under very specific medical supervision in a hospital setting. The thirst response is what keeps their sodium levels in the safe range. For mild cases, simply drinking enough water to replace fluid losses may be sufficient without needing medication.^[10][16]

Treatment duration varies. Some people, particularly those whose diabetes insipidus was caused by head injury or brain surgery, may see improvement or resolution over time. Others, especially those with genetic forms or extensive damage to the hypothalamus or pituitary, will need lifelong treatment. Regular follow-up visits every six to twelve months allow doctors to monitor how well treatment is working and adjust medications as needed.^[13]

Innovative Therapies Being Studied in Clinical Trials

While standard treatments for diabetes insipidus are well-established and generally effective, researchers continue to explore new approaches to improve outcomes and quality of life for patients. Clinical trials are investigating ways to refine diagnosis, optimize existing treatments, and develop new therapeutic strategies, though specific information about experimental drugs or novel molecules currently being tested in trials for diabetes insipidus is limited in the available medical literature.^[12]

Research efforts focus on several important areas. One key area involves improving diagnostic methods to more accurately distinguish between the different types of diabetes insipidus and identify the underlying causes more quickly. Better diagnosis can lead to more targeted treatment from the start. For example, studies are examining new biomarkers (measurable substances in blood or urine) that could help differentiate central diabetes insipidus from nephrogenic forms without requiring the traditional water deprivation test, which can be uncomfortable and requires careful medical supervision.^[12]

Another research direction explores refining how desmopressin is delivered and dosed. Scientists are working on longer-acting formulations that would require less frequent dosing, which could improve patients’ adherence to treatment and quality of life. New delivery methods beyond nasal sprays and tablets are also being investigated to find options that work better for patients who have difficulty with current forms.^[12]

For nephrogenic diabetes insipidus, particularly the genetic forms that affect children, research is examining the molecular pathways that cause the kidneys to become resistant to arginine vasopressin. Understanding these mechanisms at a cellular level could potentially lead to therapies that help restore the kidneys’ ability to respond to the hormone. Some early-stage research is looking at compounds that might enhance the kidney’s water-conserving mechanisms through alternative pathways that bypass the defective ones.^[12]

Genetic research is particularly important for families affected by hereditary forms of diabetes insipidus. Scientists are studying the specific gene mutations responsible for these conditions, which could eventually lead to targeted therapies. While gene therapy for diabetes insipidus remains in very early experimental stages and is not currently available in clinical practice, understanding the genetic basis helps doctors provide better counseling to families about inheritance patterns and future risk.^[12]

Clinical studies are also examining the best ways to manage diabetes insipidus in special populations, such as children, pregnant women, and people with other medical conditions. Pediatric research is particularly important because diabetes insipidus in infants and young children can be especially challenging to diagnose and treat. Young children cannot always communicate their thirst, and excessive urination may be mistaken for other conditions. Studies are working to develop age-appropriate treatment protocols and formulations.^[15]

Research teams across the United States, Europe, and other regions are conducting studies to better understand how patients respond to different treatment approaches over time. These observational studies track large groups of patients to identify which treatments work best for specific types of diabetes insipidus and which factors predict better or worse outcomes. This real-world evidence helps doctors make more informed treatment decisions.^[12]

Some clinical investigations focus on quality-of-life issues that affect people living with diabetes insipidus. The constant need to drink water and urinate can severely disrupt sleep, work, travel, and social activities. Research is examining strategies beyond medication to help patients manage these challenges, including behavioral interventions and patient education programs that teach coping strategies.^[12]

For people whose diabetes insipidus is caused by brain tumors or other treatable underlying conditions, ongoing research into neurosurgical techniques and tumor treatments may indirectly benefit their diabetes insipidus. Less invasive surgical approaches that cause less damage to the hypothalamus and pituitary gland could reduce the risk of developing permanent diabetes insipidus after brain surgery.^[12]

Most common treatment methods

• Hormone replacement therapy
  • Desmopressin (DDAVP) is a synthetic form of arginine vasopressin used to replace the missing hormone in central diabetes insipidus
  • Available as nasal spray, tablets, oral melts, or injections
  • Typically administered two to three times daily depending on the formulation
  • Helps the kidneys conserve water and reduce urine production
  • Highly effective for central diabetes insipidus but does not work for nephrogenic forms
• Diuretic therapy
  • Thiazide diuretics reduce the rate kidneys filter blood, paradoxically decreasing urine output
  • Used primarily for nephrogenic diabetes insipidus
  • Often combined with NSAIDs for greater effect
  • Requires monitoring for side effects and electrolyte balance
• Anti-inflammatory medications
  • NSAIDs like ibuprofen help reduce urine volume when combined with thiazide diuretics
  • Used for treating nephrogenic diabetes insipidus
  • Long-term use requires stomach protection medication to prevent ulcers
• Fluid management
  • Ensuring adequate water intake to prevent dehydration
  • For mild cases, increased fluid intake may be the only treatment needed
  • Patients must have constant access to water and should never have fluids restricted
  • Healthcare providers may recommend specific daily fluid intake targets
• Dietary modifications
  • Reducing salt and protein intake to decrease urine production
  • Primarily used for nephrogenic diabetes insipidus
  • Involves eating fewer processed foods, limiting meat, eggs, and nuts
  • Must be done under medical supervision to maintain proper nutrition
• Treatment of underlying causes
  • Addressing brain tumors, head injuries, or infections that cause central diabetes insipidus
  • Stopping or changing medications like lithium that cause nephrogenic diabetes insipidus
  • Correcting electrolyte imbalances such as high calcium or low potassium levels